An organic anion transporter 1 (oat1)-centered metabolic network

Journal of Biological Chemistry

Volumn 291, Issue 37, 2016, Pages 19474-19486

  Liu, Henry C ^a   Jamshidi, Neema ^a   Chen, Yuchen ^c   Eraly, Satish A ^b   Cho, Sai Yee ^c   Bhatnagar, Vibha ^d   Wu, Wei ^b   Bush, Kevin T ^e   Abagyan, Ruben ^g   Palsson, Bernhard O ^a   Nigam, Sanjay K ^a,b,e,f,h  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Department of Chemistry and Biochemistry ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; FATTY ACIDS; METABOLITES; NUCLEOTIDES; REMOTE SENSING;

BIOLOGICAL PATHWAYS; CHRONIC KIDNEY DISEASE; ENDOGENOUS COMPOUND; METABOLIC INTERACTIONS; METABOLIC SYNDROMES; METABOLOMICS DATA; SIGNALING MOLECULES; SIGNALING PATHWAYS;

METABOLISM;

CYCLIC NUCLEOTIDE; FATTY ACID; ORGANIC ANION TRANSPORTER 1; POLYAMINE; PROSTAGLANDIN; TRYPTOPHAN; UREMIC TOXIN; URIC ACID; VITAMIN; SLC22A6 PROTEIN, MOUSE;

ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; ANIMAL; BIOLOGICAL MODEL; METABOLISM; METABOLOME; MOUSE; PHYSIOLOGY;

ANIMALS; METABOLOME; MICE; MODELS, BIOLOGICAL; ORGANIC ANION TRANSPORT PROTEIN 1;

EID: 84987615793     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.745216     Document Type: Article

References (76)

1. César-Razquin, A., Snijder, B., Frappier-Brinton, T., Isserlin, R., Gyimesi, G., Bai, X., Reithmeier, R. A., Hepworth, D., Hediger, M. A., Edwards, A. M., and Superti-Furga, G. (2015) A call for systematic research on solute carriers. Cell 162, 478-487
2. Nigam, S. K. (2015) What do drug transporters really do? Nat. Rev. Drug Discov. 14, 29-44
3. Wu, W., Jamshidi, N., Eraly, S. A., Liu, H. C., Bush, K. T., Palsson, B. O., and Nigam, S. K. (2013) Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab. Dispos. 41, 1825-1834
4. Wu, W., Dnyanmote, A. V., and Nigam, S. K. (2011) Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol. Pharmacol. 79, 795-805
5. Wu, W., Bush, K. T., Liu, H. C., Zhu, C., Abagyan, R., and Nigam, S. K. (2015) Shared ligands between organic anion transporters (OAT1 and OAT6) and odorant receptors. Drug Metab. Dispos. 43, 1855-1863
6. Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., and Nigam, S. K. (2008) Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J. Biol. Chem. 283, 8654-8663
7. Nigam, S. K., Bush, K. T., Martovetsky, G., Ahn, S. Y., Liu, H. C., Richard, E., Bhatnagar, V., and Wu, W. (2015) The organic anion transporter (OAT) family: a systems biology perspective. Physiol. Rev. 95, 83-123
8. Kaler, G., Truong, D. M., Sweeney, D. E., Logan, D. W., Nagle, M., Wu, W., Eraly, S. A., and Nigam, S. K. (2006) Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions. Biochem. Biophys. Res. Commun. 351, 872- 876
9. Kaler, G., Truong, D. M., Khandelwal, A., Nagle, M., Eraly, S. A., Swaan, P. W., and Nigam, S. K. (2007) Structural variation governs substrate spec-ificity for organic anion transporter (OAT) homologs: potential remote sensing by OAT family members. J. Biol. Chem. 282, 23841-23853
10. Ahn, S. Y., and Nigam, S. K. (2009) Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol. Pharmacol. 76, 481-490
11. Ahn, S. Y., Jamshidi, N., Mo, M. L., Wu, W., Eraly, S. A., Dnyanmote, A., Bush, K. T., Gallegos, T. F., Sweet, D. H., Palsson, B.Ø ., and Nigam, S. K. (2011) Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis. J. Biol. Chem. 286, 31522-31531
12. Hester, E. K. (2012) HIV medications: an update and review of metabolic complications. Nutr. Clin. Pract. 27, 51-64
13. Buscemi, S., Nicolucci, A., Lucisano, G., Galvano, F., Grosso, G., Massenti, F. M., Amodio, E., Bonura, A., Sprini, D., and Rini, G. B. (2013) Impact of chronic diuretic treatment on glucose homeostasis. Diabetol. Metab. Syndr. 5, 80
14. Prentice, K. J., Luu, L., Allister, E. M., Liu, Y., Jun, L. S., Sloop, K. W., Hardy, A. B., Wei, L., Jia, W., Fantus, I. G., Sweet, D. H., Sweeney, G., Retnakaran, R., Dai, F. F., and Wheeler, M. B. (2014) The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. Cell Metab. 19, 653-666
15. Sharma, K., Karl, B., Mathew, A. V., Gangoiti, J. A., Wassel, C. L., Saito, R., Pu, M., Sharma, S., You, Y. H., Wang, L., Diamond-Stanic, M., Lindenmeyer, M. T., Forsblom, C., Wu, W., Ix, J. H., et al. (2013) Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J. Am. Soc. Nephrol. 24, 1901-1912
16. Lopez-Nieto, C. E., You, G., Barros, E. J. G., Beier, D. R., and Nigam, S. K. (1996) Molecular cloning and characterization of a novel transport protein with very high expression in the kidney. J. Am. Soc. Nephrol. 7, 1301
17. Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J. Biol. Chem. 272, 6471- 6478
18. Ahn, S. Y., Eraly, S. A., Tsigelny, I., and Nigam, S. K. (2009) Interaction of organic cations with organic anion transporters. J. Biol. Chem. 284, 31422-31430
19. Burckhardt, G., and Burckhardt, B. C. (2011) In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. Handb. Exp. Pharmacol. 201, 29-104
20. Emami Riedmaier, A., Nies, A. T., Schaeffeler, E., and Schwab, M. (2012) Organic anion transporters and their implications in pharmacotherapy. Pharmacol. Rev. 64, 421-449
21. Pavlova, A., Sakurai, H., Leclercq, B., Beier, D. R., Yu, A. S., and Nigam, S. K. (2000) Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am. J. Physiol. Renal Physiol. 278, F635- 643
22. VanWert, A. L., Gionfriddo, M. R., and Sweet, D. H. (2010) Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm. Drug Dispos. 31, 1-71
23. Eraly, S. A., Vallon, V., Vaughn, D. A., Gangoiti, J. A., Richter, K., Nagle, M., Monte, J. C., Rieg, T., Truong, D. M., Long, J. M., Barshop, B. A., Kaler, G., and Nigam, S. K. (2006) Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J. Biol. Chem. 281, 5072-5083
24. Møller, J. V., and Sheikh, M. I. (1982) Renal organic anion transport system: pharmacological, physiological, and biochemical aspects. Pharmacol Rev 34, 315-358
25. Saito, H. (2010) Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications. Pharmacol. Ther. 125, 79-91
26. Eraly, S. A., Vallon, V., Rieg, T., Gangoiti, J. A., Wikoff, W. R., Siuzdak, G., Barshop, B. A., and Nigam, S. K. (2008) Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol. Genomics 33, 180-192
27. Wikoff, W. R., Nagle, M. A., Kouznetsova, V. L., Tsigelny, I. F., and Nigam, S. K. (2011) Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J. Proteome Res. 10, 2842-2851
28. Vallon, V., Eraly, S. A., Wikoff, W. R., Rieg, T., Kaler, G., Truong, D. M., Ahn, S. Y., Mahapatra, N. R., Mahata, S. K., Gangoiti, J. A., Wu, W., Barshop, B. A., Siuzdak, G., and Nigam, S. K. (2008) Organic anion transporter
29. contributes to the regulation of blood pressure. J. Am. Soc. Nephrol. 19, 1732-1740
30. Vallon, V., Eraly, S. A., Rao, S. R., Gerasimova, M., Rose, M., Nagle, M., Anzai, N., Smith, T., Sharma, K., Nigam, S. K., and Rieg, T. (2012) A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am. J. Physiol. Renal Physiol. 302, F1293-1299
31. Sigurdsson, M. I., Jamshidi, N., Steingrimsson, E., Thiele, I., and Palsson, B. Ø . (2010) A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst Biol 4, 140
32. Becker, S. A., and Palsson, B. O. (2008) Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol. 4, e1000082
33. Mahadevan, R., and Schilling, C. H. (2003) The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab. Eng. 5, 264-276
34. Raman, K., and Chandra, N. (2009) Flux balance analysis of biological systems: applications and challenges. Brief Bioinform. 10, 435-449
35. Knies, D., Wittmüβ, P., Appel, S., Sawodny, O., Ederer, M., and Feuer, R. (2015) Modeling and simulation of optimal resource management during the diurnal cycle in Emiliania huxleyi by genome-scale reconstruction and an extended flux balance analysis approach. Metabolites 5, 659-676
36. Chang, R. L., Xie, L., Xie, L., Bourne, P. E., and Palsson, B. Ø . (2010) Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput. Biol. 6, e1000938
37. Förster, J., Famili, I., Fu, P., Palsson, B. Ø ., and Nielsen, J. (2003) Genomescale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res 13, 244-253
38. Bordbar, A., and Palsson, B. O. (2012) Using the reconstructed genomescale human metabolic network to study physiology and pathology. J. Intern. Med. 271, 131-141
39. Duan, P., Li, S., Ai, N., Hu, L., Welsh, W. J., and You, G. (2012) Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization. Mol. Pharm. 9, 3340-3346
40. Wolman, A. T., Gionfriddo, M. R., Heindel, G. A., Mukhija, P., Witkowski, S., Bommareddy, A., and Vanwert, A. L. (2013) Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics. Drug Metab. Dispos. 41, 791- 800
41. Elion, G. B. (1989) Nobel lecture: the purine path to chemotherapy. Biosci. Rep. 9, 509-529
42. Hitchings, G. H., Jr.(1989) Nobel lecture in physiology or medicine-1988: selective inhibitors of dihydrofolate reductase. In Vitro Cell Dev. Biol. 25, 303-310
43. Gupta, S., and Aires-de-Sousa, J. (2007) Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness. Mol. Divers 11, 23-36
44. Karakoc, E., Sahinalp, S. C., and Cherkasov, A. (2006) Comparative QSARand fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds. J. Chem. Inf. Model 46, 2167-2182
45. Khanna, V., and Ranganathan, S. (2009) Physiochemical property space distribution among human metabolites, drugs and toxins. BMC Bioinform. 10, S10
46. O'Hagan, S., and Kell, D. B. (2015) Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites. Front Pharmacol 6, 105
47. Kouznetsova, V. L., Tsigelny, I. F., Nagle, M. A., and Nigam, S. K. (2011) Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1). Bioorg. Med. Chem. 19, 3320-3340
48. Totrov, M., and Abagyan, R. (2008) Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr. Opin. Struct. Biol. 18, 178-184
49. Liu, H. C., Goldenberg, A., Chen, Y., Lun, C., Wu, W., Bush, K. T., Balac, N., Rodriguez, P., Abagyan, R., and Nigam, S. K. (2016) Analysis of molecular properties of drugs interacting with SLC22 transporters, OAT1, OAT3, OCT1, OCT2: A machine-learning approach. J. Pharmacol. Exp. Ther. pii: jpet.116.232660 Downloaded from http://www.jbc.org/ at ELSEVIER BV on September 9, 2016
50. Hodson, L., and Karpe, F. (2013) Is there something special about palmitoleate? Curr. Opin. Clin. Nutr. Metab. Care 16, 225-231
51. Karnovsky, A., Weymouth, T., Hull, T., Tarcea, V. G., Scardoni, G., Laudanna, C., Sartor, M. A., Stringer, K. A., Jagadish, H. V., Burant, C., Athey, B., and Omenn, G. S. (2012) Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics 28, 373-380
52. Xia, J., Sinelnikov, I. V., Han, B., and Wishart, D. S. (2015) MetaboAnalyst 3.0: making metabolomics more meaningful. Nucleic Acids Res. 43, W251-257
53. Pritchard, J. B. (1995) Intracellular α-ketoglutarate controls the efficacy of renal organic anion transport. J. Pharmacol. Exp. Ther. 274, 1278-1284
54. Vanholder, R., De Smet, R., Glorieux, G., Argiles, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., Deppisch, R., Descamps-Latscha, B., Henle, T., Jorres, A., Lemke, H. D., et al. (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934-1943
55. Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., Argiles, A., and European Uremic Toxin Work Group (2012) Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 23, 1258-1270
56. Bush, K. T., Nagle, M., Truong, D. M., Bhatnagar, V., Kaler, G., Eraly, S. A., Wu, W., and Nigam, S. K. (2014) Organic anion transporters. in Drug transporters: Molecular characterization and role in drug disposition (You, G., and Morris, M. E., eds) 2nd Ed., pp. 25-42, John Wiley & Sons, Inc., Hoboken, NJ
57. Lee, S. C., Zhang, L., and Huang, S. M. (2014) Regulatory science perspectives on transporter studies in drug development. in Drug Transporters: Molecular Characterization and Role in Drug Disposition (You, G., and Morris, M. E., eds) 2nd Ed., pp. 473-487, John Wiley & Sons, Inc., Hoboken, NJ
58. Eraly, S. A., Blantz, R. C., Bhatnagar, V., and Nigam, S. K. (2003) Novel aspects of renal organic anion transporters. Curr. Opin. Nephrol. Hypertens. 12, 551-558
59. Nigam, S. K., Wu, W., Bush, K. T., Hoenig, M. P., Blantz, R. C., and Bhatnagar, V. (2015) Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters. Clin. J. Am. Soc. Nephrol. 10, 2039-2049
60. Bhatnagar, V., Richard, E. L., Wu, W., Nievergelt, C. M., Lipkowitz, M. S., Jeff, J., Maihofer, A. X., and Nigam, S. K. (2016) Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling. Clin. Kidney J. 9, 444-453
61. Schuetz, J. D., Swaan, P. W., and Tweedie, D. J. (2014) The role of transporters in toxicity and disease. Drug Metab. Dispos. 42, 541-545
62. Zhu, C., Nigam, K. B., Date, R. C., Bush, K. T., Springer, S. A., Saier, M. H., Jr, Wu, W., and Nigam, S. K. (2015) Evolutionary analysis and classification of OATs, OCTs, OCTNs, and other SLC22 transporters: structurefunction implications and analysis of sequence motifs. PLoS ONE 10, e0140569
63. Nagle, M. A., Truong, D. M., Dnyanmote, A. V., Ahn, S. Y., Eraly, S. A., Wu, W., and Nigam, S. K. (2011) Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling. J. Biol. Chem. 286, 243-251
64. Nagle, M. A., Wu, W., Eraly, S. A., and Nigam, S. K. (2013) Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue. Neurosci. Lett. 534, 133-138
65. Sinxadi, P. Z., Dave, J. A., Samuels, D. C., Heckmann, J. M., Maartens, G., Levitt, N. S., Wester, C. W., Haas, D. W., and Hulgan, T. (2013) Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected black South Africans: a pilot study. AIDS Res. Hum. Retroviruses 29, 1031-1039
66. Monier, P. L., and Wilcox, R. (2004) Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults. Am. J. Med. Sci. 328, 48-56
67. Anderson, P. L., Kakuda, T. N., and Lichtenstein, K. A. (2004) The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities. Clin. Infect. Dis. 38, 743-753
68. Lewis, W. (2003) Mitochondrial DNA replication, nucleoside reversetranscriptase inhibitors, and AIDS cardiomyopathy. Prog. Cardiovasc. Dis. 45, 305-318
69. Vallon, V., Rieg, T., Ahn, S. Y., Wu, W., Eraly, S. A., and Nigam, S. K. (2008) Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am. J. Physiol. Renal Physiol. 294, F867- 873
70. Sweeney, D. E., Vallon, V., Rieg, T., Wu, W., Gallegos, T. F., and Nigam, S. K. (2011) Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney. Mol. Pharmacol. 80, 147-154
71. Torres, A. M., Dnyanmote, A. V., Bush, K. T., Wu, W., and Nigam, S. K. (2011) Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury. J. Biol. Chem. 286, 26391-26395
72. Chen, Y. C., Totrov, M., and Abagyan, R. (2014) Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping. Future Med. Chem. 6, 1741-1755
73. Totrov, M. (2008) Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR. Chem. Biol. Drug Des. 71, 15-27
74. Mitrea, C., Taghavi, Z., Bokanizad, B., Hanoudi, S., Tagett, R., Donato, M., Voichita, C., and DrǍghici, S. (2013) Methods and approaches in the topology-based analysis of biological pathways. Front. Physiol. 4, 278
75. Wang, R. S., Oldham, W. M., and Loscalzo, J. (2014) Network-based association of hypoxia-responsive genes with cardiovascular diseases. New J. Phys. 16, 105014
76. Zhang, Y., Fan, H., Xu, J., Xiao, Y., Xu, Y., Li, Y., and Li, X. (2013) Network analysis reveals functional cross-links between disease and inflammation genes. Sci. Rep. 3, 3426